Tuesday, September 15, 2026

Samsung Galaxy S25 Edge and Z Fold7 Prices Surge: What You Need to Know!

Samsung's smartphone prices are rising due to soaring semiconductor costs, breaking the norm of declining prices in tech.

AI Just Made Cybersecurity Easier with This No-Code Builder

Blink Ops launches a No-Code Security Agent Builder, allowing users to create custom security processes without coding skills.

Tesla Soars 2% Amid U.S.-China Tariff Tensions, Nasdaq Rebounds

U.S. tariffs on China escalate trade tensions, yet Tesla's stock rises amid a broader market rally, closing at $392.21.

News1

Boryung to Spin Off Sales and Marketing Business, Establishing 100%-Owned Subsidiary Boryung Pharma Solution

Boryung plans to separate its prescription-drug sales and marketing operations into a wholly owned subsidiary, Boryung Pharma Solution, as part of its strategy to build a specialized commercial platform.

Celltrion Submits U.S. Phase 4 IND for High-Dose 240 mg Zymfentra

Celltrion has submitted a U.S. Phase 4 trial application to support the use of a higher 240 mg dose of Zymfentra, aiming to expand personalized dosing options and strengthen the drug's position in the U.S. market.

Blood Proteins May Offer Clues to Alzheimer’s Antibody Treatment Benefits and Side-Effect Risks

A South Korean study found that blood levels of complement proteins C1q and C3 may help predict amyloid reduction and ARIA risk in patients receiving lecanemab, though larger studies are needed.

Pentrym Confirms Combination Benefits With Existing Cancer Drugs, Targets “False Resistance”

Pentrym is testing whether targeting the tumor microenvironment alongside existing cancer drugs can overcome “false resistance” and improve treatment effectiveness.

YH42946: The Promising HER2 Targeted Oral Treatment Set to Transform Cancer Care in 2026

Yuhan Corporation will reveal early results of its oral HER2-targeted therapy candidate 'YH42946' in clinical trials by year-end.

SK Biopharm Achieves MSCI ESG AAA Rating for 3rd Consecutive Year: What It Means for the Pharma Industry

SK Biopharm has achieved the highest AAA rating in MSCI's ESG evaluation for three consecutive years.

LG RONi: The Revolutionary AI Cleaning Robot with 100°C Steam – Is It Worth the Hype?

LG Electronics captivated passersby with unique outdoor ads for its LG HomeBot AI Object Collection RONi in Seoul's key areas.

Are Your Robot Vacuums Safe? Privacy Risks in Samsung, LG, and Xiaomi Models Revealed!

Robot vacuum images are encrypted and sent to users' smartphones, with no storage on company servers. Voice commands are processed and deleted.

Explore the New KGM SUVs: New Torres, Actyon Hybrid, and Musso EV for Your Perfect Holiday Getaway

This Chuseok, returning home has shifted from family visits to include travel, relaxation, and leisure activities like camping.

2026 Lexus All-New ES: Unveiling Hybrid & BEV Models with Impressive Range

Lexus Korea will start pre-orders for the all-new ES sedan from September 14, with the official launch set for next month.

Best Abstract Award at KCR 2026: Discover the Impact of AI on Chest X-Ray Analysis

AI double reading of chest X-rays by doctors recognized at Korea's largest radiology conference for enhancing diagnostic accuracy.

TXN10128: Breakthrough Oral ENPP1 Inhibitor Shows 44.4% Tumor Reduction in EGFR Mutation Lung Cancer

TXINNO Bioscience's new drug trial shows tumor reduction in 4 out of 9 patients with EGFR-mutated lung cancer who failed prior treatments.

How AI is Revolutionizing Digital Health: Insights from Welt CEO Kang Sung-ji

Exploring ways to quickly uncover unknown factors that lead to patient illness and death, driven by medical curiosity.

ASleep vs. Traditional Methods: The Future of Sleep Apnea Diagnosis and Treatment

ASleep partners with Air Liquide Healthcare to expand its sleep apnea screening and patient management services.

Top News

- Our Sponsors Ad -

Follow us